HomeAI · summaries
Storia in 3 fonti
Antares gets $105M from Novartis for new cancer drugs
Adam Friedman, CEO of the Scorpion Therapeutics spinout, said the deal helps both companies accelerate research "faster than either of us could alone."
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
endpoints.news
Novartis taps Antares in small molecule discovery pact with $105M upfront
Antares Therapeutics inks $105M upfront deal with Novartis to discover small molecules against undruggable cancer targets, with up to $1.8B in milestones.
- ·
benzinga.com
Novartis, Antares Partner To Pursue Undruggable Cancer Targets In $1.9 Billion Deal - Novartis (NYSE:NVS)
Antares inks Novartis collaboration worth up to $1.9 billion to develop therapies targeting hard-to-treat cancers.
